ENO2 and early-onset autosomal dominant Alzheimer disease: Taking into account the established role of α7 nAChRs in neuroinflammation, the results of our study demonstrate a therapeutic potential of NSE in treating neuroinflammation-dependent neurodegenerative disorders, like Alzheimer disease.